eClinical solutions Market by Product (Clinical Trial Management Systems, Clinical Data Integration Platforms, Clinical Analytics Platforms , Randomization & Trial Supply Management, Electronic Data Capture & Clinical Data Management Systems , Electronic Clinical Outcome Assessment Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions, Safety Solutions and Other eClinical Solutions ), Mode of Delivery (On Premise and Cloud Based), Clinical Trail Phase (Phase I, Phase II, Phase III and Phase IV) and End User (Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations, Academic Research Institutes & Others) and Geography: Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026016 | Pages: 100 | Industry: Healthcare IT | Date: Sep 2022 | Type: Global

The market crossed US$ 8.0 billion mark in 2022 and is expected to hit US$ 18.0 billion by 2030, recording a CAGR of 13.0% during the forecast period.

eClinical solutions market has been significantly growing with the growing uptake of cloud computing and the surge in demand for improved data standardization.

Apart from this, eClinical solutions also improve eClinical platform performance, which increases clinical trial efficacy, and diminish the cost by eliminating redundant data entry. The contract research organization segment is expected to dominate the market during the forecast period. Several factors such as the inclination of biotechnological companies to lower overall investments enhance clinical trials and streamline research workload.

Within the report, the market is segmented into product, mode of delivery, phase, end-user, and geography. By product type, the market is further segmented into clinical trial management systems, clinical data integration platforms, clinical analytics platforms, randomization, and trial supply management, electronic data capture and clinical data management systems, electronic clinical outcome assessment solutions, electronic trial master file systems, regulatory information management solutions, safety solutions, and other eClinical solutions. On the basis of mode of delivery, the market is bifurcated into on-premise and cloud-based. By clinical trial phase, the market is categorized into phase I clinical trial, phase II clinical trials, phase III clinical trials, and phase IV clinical trials. Based on end-user, the market is divided into pharmaceutical & biopharmaceutical companies, contract research organizations, academic research institutes, and others. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

The adoption of web-hosted solutions will empower the growth of futuristic growth.

eClinical solutions are software and applications utilized for the effective organization of clinical trials and clinical research activities. The different software under the eClinical solutions helps in managing, maintaining, and recording data and tracking deadlines, among other features. Various eClinical solutions include randomization and trial supply management (RTSM), clinical data management system (CDMS), and clinical trial management system (CTMS), among others. Web host demand offers several benefits, including easy availability, accessibility, and relatively lower investments. Additionally, these products maintain client data on a cloud server which is easily accessible through the web and requires only computer hardware with an internet connection.

COVID-19 showed a positive impact on the market’s growth.

The outbreak of COVID-19 has demonstrated a positive impact on the market's growth as the majority of pharmaceutical companies focused their research and development efforts on supporting the development of the COVID-19 vaccine. Furthermore, owing to the pandemic, several clinical trials adopted a completely virtual/hybrid model leading to a significantly increased demand for eClinical solutions. For instance, in June 2020, eClinical Solutions LLC, collaborated with Karyopharm Therapeutics on randomized clinical trials for low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. Thus, with the increasing severity of the pandemic, the demand for the development of the COVID-19 vaccine increases, accelerating market growth.

Get more information on this report :

Recent strategic developments in the eClinical solutions market

The eClinical solutions market has undergone several significant developments, and a few of these have been mentioned below:

  • In May 2021, The Tasmanian Government partnered with Oracle Corporations to use its health management system to manage the Covid-19 vaccination program.
  • In April 2021, Signant Health announced the launch of electronic informed consent offerings and enhanced capabilities with the new release of SmartSignals™ eConsent. Key product functionality updates and tiered license options provide sponsors with more control over obtaining electronic informed consent and reconsent for any study design.

Several players drive the eClinical solutions market by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. PAREXEL International Corporation, Oracle, Medidata Solutions, Inc., DATATRAK Int., ERT Clinical, CRF Health, OmniComm Systems, Inc., and IBM Watson Health are among the prominent players operating in the market.

Target audience for the report:

  • Drug developing companies
  • Contract development and manufacturing organization,
  • Drug discovery-related associations, organizations, forums, and alliances
  • Government bodies, such as regulating authorities and policymakers
  • Venture capitalists, private equity firms, and start-up companies
  • Drug distributors and sales firms
  • End users of drug discovery
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented on the basis of:

  • Product:
    • Clinical trial management systems
    • Clinical data integration platforms
    • Clinical analytics platforms
    • Randomization & trial supply management
    • Electronic data capture and clinical data management systems
    • Electronic clinical outcome assessment solutions
    • Electronic trial master file systems
    • Regulatory information management solutions
    • Safety solutions
    • Other eClinical solutions
  • Mode of delivery
    • On-premise
    • Cloud-based
  • Clinical trial phase:
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • End User:
    • Pharmaceutical & biotechnology companies
    • Contact research organizations
    • Academic and Research Institutes
    • Others
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • Medidata Solutions, Inc.
    • PAREXEL International Corporation
    • Oracle
    • DATATRAK Int
    • Bioclinica
    • ERT Clinical
    • Meiji Techno
    • OmniComm Systems, Inc.
    • IBM Watson Health  
    • Bio-Optronics, Inc.

Companies profiled
- Medidata Solutions, Inc.
- PAREXEL International Corporation
- Oracle
- DATATRAK Int
- Bioclinica
- ERT Clinical
- Meiji Techno
- OmniComm Systems, Inc.
- IBM Watson Health
- Bio-Optronics, Inc.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$1500
Site License
$2500
Enterprise License
$3500